The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD ; volume:9 ; number:3 ; day:20 ; month:7 ; year:2023 ; pages:345-357 ; date:9.2023
Pulmonary therapy ; 9, Heft 3 (20.7.2023), 345-357, 9.2023
- Creator
-
Terry, Paul D.
Dhand, Rajiv
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41030-023-00233-z
- URN
-
urn:nbn:de:101:1-2023110609375222282247
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Terry, Paul D.
- Dhand, Rajiv
- SpringerLink (Online service)
Other Objects (12)
Admission prevention in COPD: non-pharmacological management
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Updated guidelines for gene nomenclature in wheat
Updated clinical guidelines experience major reporting limitations
Updated recommendations: an assessment of NICE clinical guidelines
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Correction to: Updated clinical guidelines experience major reporting limitations
Updated guidelines for chronic active Epstein–Barr virus disease
An updated review of cucurbitacins and their biological and pharmacological activities
Admission prevention in COPD: non-pharmacological management
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Updated guidelines for gene nomenclature in wheat
Updated clinical guidelines experience major reporting limitations
Updated recommendations: an assessment of NICE clinical guidelines
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Correction to: Updated clinical guidelines experience major reporting limitations
Updated guidelines for chronic active Epstein–Barr virus disease
An updated review of cucurbitacins and their biological and pharmacological activities
Admission prevention in COPD: non-pharmacological management
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Updated guidelines for gene nomenclature in wheat
Updated clinical guidelines experience major reporting limitations
Updated recommendations: an assessment of NICE clinical guidelines
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Correction to: Updated clinical guidelines experience major reporting limitations
Updated guidelines for chronic active Epstein–Barr virus disease